SAN DIEGO — Brian Koffman found himself in a situation a couple years ago that most chronic lymphocytic ... cells on one end ...

Developments in chronic lymphocytic leukemia (CLL) this year included the first CAR T-cell therapy approval for the chronic ...

Researchers sought to determine whether CAR-T therapy would be safe and effective in patients with CLL and Richter transformation.

such as chimeric antigen receptor–NK cell treatment. Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have ...

In a meta-analysis, second-generation BTK inhibitors were linked to a significantly low incidence of atrial fibrillation, ...

Trying to break from the decade-old practice of using BTK inhibitors indefinitely to treat blood cancer, AstraZeneca has ...

University of Cincinnati Cancer Center experts will present abstracts at the 66th American Society of Hematology (ASH) Annual ...

Susan L. Slager, PhD, discusses some of the recommendations for genetic testing in individuals with a family history of ...

B-cell acute lymphoblastic leukemia (B-cell ALL) is the most common childhood cancer. Despite a high overall cure rate, relapsed B-cell ALL remains a leading cause of cancer-related death among ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, whose ...

Opens in a new tab or window SAN DIEGO -- Children with newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL) lived significantly longer without disease recurrence when they received the ...